Trevi Therapeutics, Inc. (NASDAQ:TRVI) Short Interest Down 27.6% in April
Trevi Therapeutics, Inc. (NASDAQ:TRVI – Get Rating) was the target of a large decline in short ...
Read moreTrevi Therapeutics, Inc. (NASDAQ:TRVI – Get Rating) was the target of a large decline in short ...
Read more© 2022 TheDailyStock.News